Trek Therapeutics, PBC and Vertex Pharmaceuticals Incorporated Assignment and License AgreementAssignment and License Agreement • May 11th, 2020 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Massachusetts
This Assignment and License Agreement (the “Agreement”) is made and entered into as of July 12, 2016 (the “Effective Date”), by and between Vertex Pharmaceuticals Incorporated, with an address at 50 Northern Avenue, Boston, Massachusetts 02210 (together with its Affiliates, “VERTEX”) and Trek Therapeutics, PBC with an address at 125 Cambridge Park Drive, Suite 301, Cambridge, Massachusetts 02140 (“TREKtx”). VERTEX and TREKtx each may be referred to herein individually as a “Party” or collectively as the “Parties.”
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 11th, 2020 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
THIS ASSET PURCHASE AGREEMENT is entered into as of this 24th day of March, 2020, by and between Trek Therapeutics, PBC, a Delaware public benefit corporation (“Seller”), and NeuroClear Technologies, Inc., a Delaware corporation (“Buyer”).
